Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Liberty Media Corporation Series C Liberty Formula One Common Stock (FWONK) vs Revvity Inc (RVTY) Price & Performance

Liberty Media Corporation Series C Liberty Formula One Common StockTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Liberty Media Corporation Series C Liberty Formula One Common Stock vs Revvity Inc — how do they compare? Liberty Media Corporation Series C Liberty Formula One Common Stock trades at $90.85 (market cap $23.11B), while Revvity Inc trades at $151.84 (market cap $17.30B). The key difference: Liberty Media Corporation Series C Liberty Formula One Common Stock is the larger of the two by market cap, and Revvity Inc pays a 0.18% dividend while Liberty Media Corporation Series C Liberty Formula One Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liberty Media Corporation Series C Liberty Formula One Common Stock for 0 Days and Revvity Inc for 13 Days on average.

FWONKRVTY
Market Cap
$23.11B$17.30B
Volume
3,394,5961,387,588
Sector
MediaHealth
52-Week High
$106.66$157.36
52-Week Low
$81.42$82.26
Typical Hold Time
0 Days13 Days
Enterprise Value
$26.57B$19.62B
Dividend Yield
—0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Liberty Media Corporation Series C Liberty Formula One Common Stock

No Aura AI signal available yet.

Revvity Inc

RVTY trades at $155.08, down 0.34% on the day but near its 52-week high of $158.28. The stock shows strong technical momentum with bullish moving averages and has consistently beaten earnings estimates in recent quarters. Recent developments include the launch of a new diabetes detection kit in Europe and the acquisition of Human Cell Design to expand metabolic disease research capabilities. The company maintains solid profitability with 54.98% gross margins and positive cash flow trends.

RVTY presents growth potential through diagnostic expansion and AI-driven demand, though premium valuation metrics (P/E 74.56) require careful consideration. Near-term catalysts include Q3 earnings on November 3, 2026, while risks involve China market pressures and margin compression. Analyst consensus leans bullish with 52% buy ratings and a $132.13 price target, suggesting potential downside from current levels despite positive momentum.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FWONK
100% Buy0% Sell
Avg holding period · 0 Days
RVTY

No sentiment data available yet.

About Liberty Media Corporation Series C Liberty Formula One Common Stock

Liberty Media Corporation's Series C Liberty Formula One common stock is a tracking stock reflecting the economic performance of the Formula One Group, which holds Liberty Media's interests in Formula 1 racing, MotoGP, and related minority investments.

Read more on FWONK →

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY →